{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T23:52:52Z","timestamp":1790466772901,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1007\/bf02982546","type":"journal-article","created":{"date-parts":[[2008,11,3]],"date-time":"2008-11-03T17:29:42Z","timestamp":1225733382000},"page":"26-32","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cytokines in Graft-Versus-Host Disease and the Graft-Versus-Leukemia Reaction"],"prefix":"10.1007","volume":"74","author":[{"given":"H. Joachim","family":"Deeg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,7,1]]},"reference":[{"key":"BF02982546_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1083-8791(99)70011-X","volume":"5","author":"JL Ferrara","year":"1999","unstructured":"Ferrara JL, Levy R, Chao NJ. Pathophysiologic mechanisms of acute graft-vs.-host disease [review].Biol Blood Marrow Transplant. 1999;5:347\u2013356.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF02982546_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1172\/JCI6896","volume":"104","author":"GR Hill","year":"1999","unstructured":"Hill GR, Teshima T, Gerbitz A, et al. Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.J Clin Invest. 1999;104:459\u2013467.","journal-title":"J Clin Invest."},{"key":"BF02982546_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/00007890-199707270-00021","volume":"64","author":"CQ Xun","year":"1997","unstructured":"Xun CQ,Tsuchida M,Thompson JS. Delaying transplantation after total body irradiation is a simple and effective way to reduce acute graft-versus-host disease mortality after major H2 incompatible transplantation.Transplantation. 1997;64:297\u2013302.","journal-title":"Transplantation"},{"key":"BF02982546_CR4","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood.V90.8.3204","volume":"90","author":"GR Hill","year":"1997","unstructured":"Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.Blood. 1997;90:3204\u20133213.","journal-title":"Blood"},{"key":"BF02982546_CR5","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood.V95.9.2754.009k25_2754_2759","volume":"95","author":"GR Hill","year":"2000","unstructured":"Hill GR, Ferrara JL. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation [review].Blood. 2000;95:2754\u20132759.","journal-title":"Blood"},{"key":"BF02982546_CR6","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.4049\/jimmunol.136.12.4354","volume":"136","author":"G Janossy","year":"1986","unstructured":"Janossy G, Bofill M, Poulter LW, et al. Separate ontogeny of two macrophage-like accessory cell populations in the human fetus.J Immunol. 1986;136:4354\u20134361.","journal-title":"J Immunol."},{"key":"BF02982546_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1126\/science.285.5426.412","volume":"285","author":"WD Shlomchik","year":"1999","unstructured":"Shlomchik WD, Couzens MS, Tang CB, et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells.Science. 1999;285:412\u2013415.","journal-title":"Science"},{"key":"BF02982546_CR8","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1182\/blood.V91.11.4051","volume":"91","author":"K Hattori","year":"1998","unstructured":"Hattori K, Hirano T, Miyajima H, et al. Differential effects of anti-Fas ligand and anti-tumor necrosis factor alpha antibodies on acute graft-versus-host disease pathologies.Blood. 1998;91:4051\u20134055.","journal-title":"Blood"},{"key":"BF02982546_CR9","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1073\/pnas.94.4.1366","volume":"94","author":"MB Baker","year":"1997","unstructured":"Baker MB, Riley RL, Podack ER, Levy RB. Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function.Proc Natl Acad Sci U S A. 1997;94:1366\u20131371.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"BF02982546_CR10","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1172\/JCI119606","volume":"100","author":"TA Graubert","year":"1997","unstructured":"Graubert TA, DiPersio JF, Russell JH, Ley TJ. Perforin\/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation.J Clin Invest. 1997;100:904\u2013911.","journal-title":"J Clin Invest."},{"key":"BF02982546_CR11","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/00007890-199910150-00006","volume":"68","author":"S Hiroyasu","year":"1999","unstructured":"Hiroyasu S, Shiraishi M, Koji T, et al. Analysis of Fas system in pulmonary injury of graft-versus-host disease after rat intestinal transplantation.Transplantation. 1999;68:933\u2013938.","journal-title":"Transplantation"},{"key":"BF02982546_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1089\/15258160050079498","volume":"9","author":"M Lesnikova","year":"2000","unstructured":"Lesnikova M, Lesnikov V, Arrighi S, Kistler G, Pierpaoli W, Deeg HJ. Upregulation of interleukin-10 and inhibition of alloantigen responses by transferrin and transferrin-derived glycans.J Hematother Stem Cell Res. 2000;9:381\u2013392.","journal-title":"J Hematother Stem Cell Res."},{"key":"BF02982546_CR13","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.4049\/jimmunol.162.8.4373","volume":"162","author":"JE Buhlmann","year":"1999","unstructured":"Buhlmann JE, Gonzalez M, Ginther B, et al. Cutting edge: sustained expansion of CD8+ T cells requires CD154 expression by Th cells in acute graft versus host disease.J Immunol. 1999;162:4373\u20134376.","journal-title":"J Immunol."},{"key":"BF02982546_CR14","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.4049\/jimmunol.160.9.4225","volume":"160","author":"K Saito","year":"1998","unstructured":"Saito K, Sakurai J, Ohata J, et al. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28.J Immunol. 1998;160:4225\u20134231.","journal-title":"J Immunol."},{"key":"BF02982546_CR15","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1182\/blood.V95.7.2434","volume":"95","author":"N Tsukada","year":"2000","unstructured":"Tsukada N, Akiba H, Kobata T, Aizawa Y, Yagita H, Okumura K. Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation.Blood. 2000;95:2434\u20132439.","journal-title":"Blood"},{"key":"BF02982546_CR16","first-page":"289","volume":"16","author":"KR Schultz","year":"1995","unstructured":"Schultz KR, Paquet J, Bader S, Hayglass KT. Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease.Bone Marrow Transplant. 1995;16:289\u2013295.","journal-title":"Bone Marrow Transplant"},{"key":"BF02982546_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/00007890-199701150-00010","volume":"63","author":"H Schwaighofer","year":"1997","unstructured":"Schwaighofer H, Oberhuber G, Hebart H, et al. Endogenous inter-leukin 1 receptor antagonist during human bone marrow transplantation: increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapy.Transplantation. 1997;63:52\u201356.","journal-title":"Transplantation"},{"key":"BF02982546_CR18","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1182\/blood.V84.4.1342.1342","volume":"84","author":"JH Antin","year":"1994","unstructured":"Antin JH, Weinstein HJ, Guinan EC, et al. Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease.Blood. 1994;84:1342\u20131348.","journal-title":"Blood"},{"key":"BF02982546_CR19","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1097\/00007890-199906150-00015","volume":"67","author":"GR Hill","year":"1999","unstructured":"Hill GR, Cooke KR, Brinson YS, Bungard D, Ferrara JL. Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantation.Transplantation. 1999;67:1478\u20131480.","journal-title":"Transplantation"},{"key":"BF02982546_CR20","first-page":"257","volume-title":"Graft-vs.-Host Disease","author":"FT Hakim","year":"1997","unstructured":"Hakim FT, Mackall CL. The immune system: effector and target of graft-versus-host disease. In: Ferrara JLM, Deeg HJ, Burakoff SJ, eds. Graft-vs.-Host Disease, 2nd Edition Revised and Expanded. New York, NY: Marcel Dekker, Inc., 1997:257\u2013290.","edition":"2nd Edition"},{"key":"BF02982546_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/sj.bmt.1702083","volume":"25","author":"T Kozlowski","year":"2000","unstructured":"Kozlowski T, Sablinski T, Basker M, et al. Decreased graft-versus-host disease after haplotype mismatched bone marrow allografts in miniature swine following interleukin-2 treatment.Bone Marrow Transplant. 2000;25:47\u201352.","journal-title":"Bone Marrow Transplant"},{"key":"BF02982546_CR22","first-page":"1","volume":"10","author":"MR Jadus","year":"1992","unstructured":"Jadus MR, Websic HT. The role of cytokines in graft-versus-host reactions and disease.Bone Marrow Transplant. 1992;10:1\u201314.","journal-title":"Bone Marrow Transplant"},{"key":"BF02982546_CR23","first-page":"88","volume":"21","author":"JJ Clancy","year":"1989","unstructured":"Clancy JJ, Goral J, Kovacs EJ, Ellis T. Role of recombinant inter-leukin-2 (rIL-2) and large granular lymphocytes (LGLs) in acute rat graft-versus-host disease (GVHD).Transplant Proc. 1989;21:88\u201389.","journal-title":"Transplant Proc."},{"key":"BF02982546_CR24","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/S0140-6736(88)90085-2","volume":"2","author":"P Herv\u00e9","year":"1988","unstructured":"Herv\u00e9 P, Wijdenes J, Bergerat JP, Milpied N, Gaud C, Bordigoni P. Treatment of acute graft-versus-host disease with monoclonal antibody to IL-2 receptor.Lancet. 1988;2:1072\u20131073.","journal-title":"Lancet"},{"key":"BF02982546_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00007890-199007000-00010","volume":"50","author":"C Anasetti","year":"1990","unstructured":"Anasetti C, Martin PJ, Hansen JA, et al. A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease.Transplantation. 1990;50:49\u201354.","journal-title":"Transplantation"},{"key":"BF02982546_CR26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1182\/blood.V95.1.83","volume":"95","author":"D Przepiorka","year":"2000","unstructured":"Przepiorka D, Kernan NA, Ippoliti C, et al. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease.Blood. 2000;95:83\u201389.","journal-title":"Blood"},{"key":"BF02982546_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1046\/j.1537-2995.2000.40030361.x","volume":"40","author":"KV Lankford","year":"2000","unstructured":"Lankford KV, Mosunjac M, Hillyer CD. Effects of UVB radiation on cytokine generation, cell adhesion molecules, and cell activation markers in T-lymphocytes and peripheral blood HPCs.Transfusion. 2000;40:361\u2013367.","journal-title":"Transfusion"},{"key":"BF02982546_CR28","first-page":"93","volume":"26","author":"L Uharek","year":"1998","unstructured":"Uharek L, Glass B, Zeis M, et al. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).Exp Hematol. 1998;26:93\u201399.","journal-title":"Exp Hematol."},{"key":"BF02982546_CR29","first-page":"389","volume":"14","author":"H-G Klingemann","year":"1994","unstructured":"Klingemann H-G, Eaves CJ, Barnett MJ, et al. Transplantation of patients with high risk acute myeloid leukemia in first remission with autologous marrow cultured in interleukin-2 followed by inter-leukin-2 administration.Bone Marrow Transplant. 1994;14:389.","journal-title":"Bone Marrow Transplant"},{"key":"BF02982546_CR30","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/sj.bmt.1700954","volume":"20","author":"KR Meehan","year":"1997","unstructured":"Meehan KR, Verma UN, Cahill R, et al. Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlates.Bone Marrow Transplant. 1997;20:643\u2013651.","journal-title":"Bone Marrow Transplant"},{"key":"BF02982546_CR31","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1172\/JCI3906","volume":"102","author":"WJ Murphy","year":"1998","unstructured":"Murphy WJ,Welniak LA,Taub DD, et al. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.J Clin Invest. 1998;102:1742\u20131748.","journal-title":"J Clin Invest."},{"key":"BF02982546_CR32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood.V96.1.347","volume":"96","author":"W Krenger","year":"2000","unstructured":"Krenger W, Rossi S, Piali L, Hollander GA. Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells.Blood. 2000;96:347\u2013354.","journal-title":"Blood"},{"key":"BF02982546_CR33","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/sj.bmt.1702402","volume":"25","author":"Y Nawa","year":"2000","unstructured":"Nawa Y, Teshima T, Sunami K, et al. G-CSF reduces IFN-gamma and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function.Bone Marrow Transplant. 2000;25:1035\u20131040.","journal-title":"Bone Marrow Transplant"},{"key":"BF02982546_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/84659","volume":"7","author":"C King","year":"2001","unstructured":"King C, Mueller HR, Malo CM, et al. Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cyto-toxic CD8+ T-cell responses.Nat Med. 2001;7:206\u2013214.","journal-title":"Nat Med."},{"key":"BF02982546_CR35","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1172\/JCI7894","volume":"105","author":"B Nikolic","year":"2000","unstructured":"Nikolic B, Lee S, Bronson RT, Grusby MJ, Sykes M. Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets.J Clin Invest. 2000;105:1289\u20131298.","journal-title":"J Clin Invest."},{"key":"BF02982546_CR36","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1182\/blood.V93.10.3558.410k31_3558_3564","volume":"93","author":"ML Rosario del","year":"1999","unstructured":"del Rosario ML, Zucali JR, Kao KJ. Prevention of graft-versus-host disease by induction of immune tolerance with ultraviolet B-irradiated leukocytes in H-2 disparate bone marrow donor.Blood. 1999;93:3558\u20133564.","journal-title":"Blood"},{"key":"BF02982546_CR37","first-page":"92","volume":"72","author":"S Imoto","year":"2000","unstructured":"Imoto S, Oomoto Y, Murata K, et al. Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease.Int J Hematol. 2000;72:92\u201397.","journal-title":"Int J Hematol."},{"key":"BF02982546_CR38","first-page":"369","volume":"18","author":"CE Emmanouilides","year":"1996","unstructured":"Emmanouilides CE, Luo J, Baldwin G, et al. Murine IL-10 fails to reduce GVHD despite inhibition of alloreactivity in vitro.Bone Marrow Transplant. 1996;18:369\u2013375.","journal-title":"Bone Marrow Transplant"},{"key":"BF02982546_CR39","first-page":"118","volume":"2","author":"DH Fowler","year":"1996","unstructured":"Fowler DH, Breglio J, Nagel G, Hirose C, Gress RE. Allospecific CD4+, Th1\/Th2 and CD8+, Tc1\/Tc2 populations in murine GVL: type I cells generate GVL and type II cells abrogate GVL.Biol Blood Marrow Transplant. 1996;2:118\u2013125.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF02982546_CR40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/sj.bmt.1702126","volume":"25","author":"E Holler","year":"2000","unstructured":"Holler E, Roncarolo MG, Hintermeier-Knabe R, et al. Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation.Bone Marrow Transplant. 2000;25:237\u2013241.","journal-title":"Bone Marrow Transplant"},{"key":"BF02982546_CR41","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/00007890-199810150-00009","volume":"66","author":"LM Liem","year":"1998","unstructured":"Liem LM, van Houwelingen HC, Goulmy E. Serum cytokine levels after HLA-identical bone marrow transplantation.Transplantation. 1998;66:863\u2013871.","journal-title":"Transplantation"},{"key":"BF02982546_CR42","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1182\/blood.V94.11.3941","volume":"94","author":"J Cavet","year":"1999","unstructured":"Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants.Blood. 1999;94:3941\u20133946.","journal-title":"Blood"},{"key":"BF02982546_CR43","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1046\/j.1365-2567.1998.00403.x","volume":"93","author":"RM Gorczynski","year":"1998","unstructured":"Gorczynski RM, Chen Z, Zeng H, Gorczynski L, Terzioglu E. Analysis of cytokine production and V beta T-cell receptor subsets in irradiated recipients receiving portal or peripheral venous reconstitution with allogeneic bone marrow cells, with or without additional anti-cytokine monoclonal antibodies.Immunology. 1998;93:221\u2013229.","journal-title":"Immunology"},{"key":"BF02982546_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1172\/JCI3132","volume":"102","author":"GR Hill","year":"1998","unstructured":"Hill GR, Cooke KR, Teshima T, et al. Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.J Clin Invest. 1998;102:115\u2013123.","journal-title":"J Clin Invest."},{"key":"BF02982546_CR45","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/hep.510300616","volume":"30","author":"M Bozza","year":"1999","unstructured":"Bozza M, Bliss JL, Maylor R, et al. Interleukin-11 reduces T-cell-dependent experimental liver injury in mice.Hepatology. 1999;30:1441\u20131447.","journal-title":"Hepatology"},{"key":"BF02982546_CR46","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3109\/10428199909058446","volume":"33","author":"YG Yang","year":"1999","unstructured":"Yang YG, Sykes M. The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD [review].Leukemia & Lymphoma. 1999;33:409\u2013420.","journal-title":"Leukemia & Lymphoma"},{"issue":"suppl 3","key":"BF02982546_CR47","first-page":"S3","volume":"21","author":"B Glass","year":"1998","unstructured":"Glass B, Uharek L, Hartung G, et al. Immunotherapeutic aspects of allogeneic peripheral progenitor cells.Bone Marrow Transplant. 1998;21 (suppl 3):S3-S8.","journal-title":"Bone Marrow Transplant"},{"key":"BF02982546_CR48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/sj.bmt.1701819","volume":"24","author":"M Yabe","year":"1999","unstructured":"Yabe M, Yabe H, Hattori K, et al. Role of interleukin-12 in the development of acute graft-versus-host disease in bone marrow transplant patients.Bone Marrow Transplant. 1999;24:29\u201334.","journal-title":"Bone Marrow Transplant"},{"key":"BF02982546_CR49","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0925-5710(97)00117-5","volume":"67","author":"S Kumaki","year":"1998","unstructured":"Kumaki S, Minegishi M, Fujie H, et al. Prolonged secretion of IL-15 in patients with severe forms of acute graft-versus-host disease after allogeneic bone marrow transplantation in children.Int J Hematol. 1998;67:307\u2013312.","journal-title":"Int J Hematol"},{"key":"BF02982546_CR50","first-page":"1547","volume":"57","author":"JS Serody","year":"1997","unstructured":"Serody JS, Brecher ME, Dent G, Bentley SA, Frelinger JA, Shea TC. A method for the production of CD4+ chronic myelogenous leukemia-specific allogeneic T lymphocytes.Cancer Res. 1997;57:1547\u20131553.","journal-title":"Cancer Res."},{"key":"BF02982546_CR51","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1056\/NEJM200102013440507","volume":"344","author":"WW Busse","year":"2001","unstructured":"Busse WW, Lemanske RF. Advances in immunology \u2014 Asthma [review].N Engl J Med. 2001;344:350\u201362.","journal-title":"N Engl J Med."},{"key":"BF02982546_CR52","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1182\/blood.V86.11.4184.bloodjournal86114184","volume":"86","author":"G Eissner","year":"1995","unstructured":"Eissner G, Kohlhuber F, Grell M, et al. Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin.Blood. 1995;86:4184\u20134193.","journal-title":"Blood"},{"key":"BF02982546_CR53","first-page":"184","volume":"70","author":"MR Brink van den","year":"2000","unstructured":"van den Brink MR, Moore E, Horndasch KJ, Crawford JM, Murphy GF, Burakoff SJ. Fas ligand-deficientgld mice are more susceptible to graft-versus-host-disease.Transplantation. 2000;70:184\u2013191.","journal-title":"Transplantation"},{"key":"BF02982546_CR54","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1093\/intimm\/11.6.925","volume":"11","author":"K Miwa","year":"1999","unstructured":"Miwa K, Hashimoto H, Yatomi T, Nakamura N, Nagata S, Suda T. Therapeutic effect of an anti-Fas ligand mAb on lethal graft-ver-sus-host disease.Int Immunol. 1999;11:925\u2013931.","journal-title":"Int Immunol."},{"key":"BF02982546_CR55","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1006\/cimm.1999.1553","volume":"197","author":"T Iwasaki","year":"1999","unstructured":"Iwasaki T, Hamano T, Saheki K, et al. Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells.Cell Immunol. 1999;197:30\u201338.","journal-title":"Cell Immunol."},{"key":"BF02982546_CR56","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1182\/blood.V92.10.3943","volume":"92","author":"PG Middleton","year":"1998","unstructured":"Middleton PG, Taylor PR, Jackson G, Proctor SJ, Dickinson AM. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants.Blood. 1998;92:3943\u20133948.","journal-title":"Blood"},{"key":"BF02982546_CR57","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/blood.V94.2.825","volume":"94","author":"OI Krijanovski","year":"1999","unstructured":"Krijanovski OI, Hill GR, Cooke KR, et al. Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease.Blood. 1999;94:825\u201331.","journal-title":"Blood"},{"key":"BF02982546_CR58","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1182\/blood.V79.12.3362.bloodjournal79123362","volume":"79","author":"P Herv\u00e9","year":"1992","unstructured":"Herv\u00e9 P, Flesch M, Tiberghien J, et al. Phase I-II trial of a monoclonal anti-tumor necrosis factor \u03b1 antibody for the treatment of refractory severe acute graft-versus-host disease.Blood. 1992;79:3362\u20133368.","journal-title":"Blood"},{"key":"BF02982546_CR59","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/sj.bmt.1701478","volume":"22","author":"HP Brok","year":"1998","unstructured":"Brok HP, Vossen JM, Heidt PJ. IFN-gamma-mediated prevention of graft-versus-host disease: pharmacodynamic studies and influence on proliferative capacity of chimeric spleen cells.Bone Marrow Transplant. 1998;22:1005\u20131010.","journal-title":"Bone Marrow Transplant"},{"key":"BF02982546_CR60","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1182\/blood.V90.11.4651","volume":"90","author":"YG Yang","year":"1997","unstructured":"Yang YG, Sergio JJ, Pearson DA, Szot GL, Shimizu A, Sykes M. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.Blood. 1997;90:4651\u20134660.","journal-title":"Blood"},{"key":"BF02982546_CR61","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.4049\/jimmunol.161.6.2848","volume":"161","author":"A Shustov","year":"1998","unstructured":"Shustov A, Nguyen P, Finkelman F, Elkon KB, Via CS. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.J Immunol. 1998;161:2848\u20132855.","journal-title":"J Immunol."},{"key":"BF02982546_CR62","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.4049\/jimmunol.162.8.4464","volume":"162","author":"K Sato","year":"1999","unstructured":"Sato K, Nagayama H, Takahashi TA. Aberrant CD3- and CD28- mediated signaling events in cord blood T cells are associated with dysfunctional regulation of Fas ligand-mediated cytotoxicity.J Immunol. 1999;162:4464\u20134471.","journal-title":"J Immunol."},{"key":"BF02982546_CR63","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1056\/NEJM200006223422501","volume":"342","author":"V Rocha","year":"2000","unstructured":"Rocha V, Wagner JE, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling.N Engl J Med. 2000;342:1846\u20131854.","journal-title":"N Engl J Med."},{"key":"BF02982546_CR64","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1046\/j.1365-2567.2000.00919.x","volume":"99","author":"T Iwasaki","year":"2000","unstructured":"Iwasaki T, Hamano T, Saheki K, et al. Graft-versus-host-disease-associated donor cell engraftment in an F1 hybrid model is dependent upon the Fas pathway.Immunology. 2000;99:94\u2013100.","journal-title":"Immunology"},{"key":"BF02982546_CR65","first-page":"3494","volume":"37","author":"SJ Chester","year":"1979","unstructured":"Chester SJ, Esparza AR, Flinton LJ, Simon JD, Kelley RJ, Albala MM. Further development of a successful protocol of graft-versus-leukemia without fatal graft-versus-host disease in AKR mice.Cancer Res. 1979;37:3494\u20133496.","journal-title":"Cancer Res."},{"key":"BF02982546_CR66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1182\/blood.V92.1.101.413k14_101_107","volume":"92","author":"T Mori","year":"1998","unstructured":"Mori T, Nishimura T, Ikeda Y, Hotta T, Yagita H, Ando K. Involvement of Fas-mediated apoptosis in the hematopoietic progenitor cells of graft-versus-host reaction-associated myelosuppression.Blood. 1998;92:101\u2013107.","journal-title":"Blood"},{"key":"BF02982546_CR67","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4049\/jimmunol.164.1.469","volume":"164","author":"MR Brink van den","year":"2000","unstructured":"van den Brink MR, Moore E, Horndasch KJ, et al. Fas-deficient lpr mice are more susceptible to graft-versus-host disease.J Immunol. 2000;164:469\u2013480.","journal-title":"J Immunol."},{"key":"BF02982546_CR68","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1182\/blood.V93.8.2738","volume":"93","author":"N Tsukada","year":"1999","unstructured":"Tsukada N, Kobata T, Aizawa Y, Yagita H, Okumura K. Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation.Blood. 1999;93:2738\u20132747.","journal-title":"Blood"},{"key":"BF02982546_CR69","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1083-8791(99)70012-1","volume":"5","author":"M Ito","year":"1999","unstructured":"Ito M, Shizuru JA. Graft-vs.-lymphoma effect in an allogeneic hematopoietic stem cell transplantation model.Biol Blood Marrow Transplant. 1999;5:357\u2013368.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF02982546_CR70","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00007890-199901150-00009","volume":"67","author":"LM Liem","year":"1999","unstructured":"Liem LM, Fibbe WE, van Houwelingen HC, Goulmy E. Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease.Transplantation. 1999;67:59\u201365.","journal-title":"Transplantation"},{"key":"BF02982546_CR71","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1172\/JCI1268","volume":"101","author":"O Asai","year":"1998","unstructured":"Asai O, Longo DL,Tian ZG, et al. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.J Clin Invest. 1998;101:1835\u20131842.","journal-title":"J Clin Invest."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02982546\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982546.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982546.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:27:46Z","timestamp":1684618066000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02982546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["BF02982546"],"URL":"https:\/\/doi.org\/10.1007\/bf02982546","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}